Tomas Aparicio-Fernandez

Murcia, MU, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Prescription of PARP inhibitors (iPARP) in metastatic castration-resistant prostate cancer: a position paper of the Spanish Association of Urology (AEU) and its Uro-Oncology Group (GUO).

Prescription of PARP inhibitors (iPARP) in metastatic castration-resistant prostate cancer: a position paper of the Spanish Association of Urology (AEU) and its Uro-Oncology Group (GUO).

Journal: Actas urologicas espanolas

Published: September 15, 2025

Accuracy of large language models in interpreting urological clinical guidelines: a comparative study with expert evaluation.

Accuracy of large language models in interpreting urological clinical guidelines: a comparative study with expert evaluation.

Journal: Therapeutic advances in urology

Published: August 26, 2025

Interplay of KIR2DL5, nitric oxide, and tobacco smoking in predisposition to bladder cancer.

Interplay of KIR2DL5, nitric oxide, and tobacco smoking in predisposition to bladder cancer.

Journal: Frontiers in cell and developmental biology

Published: May 20, 2025

Differential Role of NKG2A/HLA-E Interaction in the Outcomes of Bladder Cancer Patients Treated with M. bovis BCG or Other Therapies.

Differential Role of NKG2A/HLA-E Interaction in the Outcomes of Bladder Cancer Patients Treated with M. bovis BCG or Other Therapies.

Journal: Biomedicines

Published: November 13, 2024

Early diagnosis of prostate cancer in healthy men with germline mutations in DNA Damage Response (DDR) pathways: A literature review and proposal for a screening strategy.

Early diagnosis of prostate cancer in healthy men with germline mutations in DNA Damage Response (DDR) pathways: A literature review and proposal for a screening strategy.

Journal: Actas urologicas espanolas

Published: November 11, 2024

Exploring the Immunoresponse in Bladder Cancer Immunotherapy.

Exploring the Immunoresponse in Bladder Cancer Immunotherapy.

Journal: Cells

Published: September 30, 2024

Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm Results.

Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm Results.

Journal: Cancer medicine

Published: June 24, 2024

Impact of the COVID-19 Pandemic on Cancer Diagnosis in Madrid (Spain) Based on the RTMAD Tumor Registry (2019-2021).

Impact of the COVID-19 Pandemic on Cancer Diagnosis in Madrid (Spain) Based on the RTMAD Tumor Registry (2019-2021).

Journal: Cancers

Published: December 03, 2022

Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial.

Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial.

Journal: European urology oncology

Published: May 18, 2022

Ureteroiliac Fistula: Bleeding of Unknown Origin-Case Report and Review of the Literature.

Ureteroiliac Fistula: Bleeding of Unknown Origin-Case Report and Review of the Literature.

Journal: Journal of endourology case reports

Published: January 18, 2021

Assessment of the Grades of Vesicoureteral Reflux in Stented Ureters: An Experimental Study.

Assessment of the Grades of Vesicoureteral Reflux in Stented Ureters: An Experimental Study.

Journal: Urologia internationalis

Published: October 23, 2020

Incidence of upper tract urothelial carcinoma in Spain.

Incidence of upper tract urothelial carcinoma in Spain.

Journal: Actas urologicas espanolas

Published: January 19, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026